Roots Analysis (@RootsAnalysis) header
Roots Analysis (@RootsAnalysis) profile picture

Roots Analysis

@RootsAnalysis

Roots Analysis is a global market research, competitive intelligence & strategic consulting firm serving pharma, biotech, medical device and healthcare industry

 Mohali
rootsanalysis.com
Joined May 2013
  • Tweets10.7K
  • Following482
  • Followers792
2.4KMedia
Photo by Roots Analysis (@RootsAnalysis)Photo by Roots Analysis (@RootsAnalysis)Photo by Roots Analysis (@RootsAnalysis)Photo by Roots Analysis (@RootsAnalysis)Photo by Roots Analysis (@RootsAnalysis)Photo by Roots Analysis (@RootsAnalysis)Photo by Roots Analysis (@RootsAnalysis)Photo by Roots Analysis (@RootsAnalysis)Photo by Roots Analysis (@RootsAnalysis)Photo by Roots Analysis (@RootsAnalysis)
Roots Analysis retweeted
Roots Analysis (@RootsAnalysis) profile picture
Roots Analysis
@RootsAnalysisNov 3
Replying to @exosome
An important milestone for senescence-targeted immunotherapy. The real breakthrough will be demonstrating selective clearance of senescent cells with a strong safety profile. Will the initial clinical study assess senescence biomarkers alongside cancer treatment outcomes?
1
3
3
337
Roots Analysis retweeted
Roots Analysis (@RootsAnalysis) profile picture
Roots Analysis
@RootsAnalysisAug 13
What’s shaping the plasmid DNA manufacturing market? GMP-grade plasmid DNA and viral vector manufacturing are emerging as key demand drivers as cell & gene therapies continue to advance. Explore the market outlook through 2035. 🧬 #PlasmidDNA #GeneTherapy #CellTherapy #Biotech
1
1
1
81
Roots Analysis retweeted
STAT (@statnews) profile picture
STAT
@statnews5 Sep 2021
“The U.S. does not have current domestic production capacity for many generic antibiotics for children’s ear infections, strep throat, pneumonia, urinary tract infections, sexually transmitted diseases, Lyme disease, superbugs, and other infections." buff.ly/2Yv9fQL
5
19
1
52
Today CGT Catapult celebrates the one-year anniversary since receiving funding from @beisgovuk to set up our world-class #vaccine and #celltherapy #genetherapy #manufacturing innovation facility in Braintree, Essex 🧬💉 Read more!👉ow.ly/8pn050FC2pR youtube.com/watch?v=Dal8_4CC…
1
2
1
8
There is no shortage of things to worry about. Temporary #anxiety can be a healthy response to uncertainty and danger, but constant worry and nervousness may be a sign of generalized anxiety disorder: bit.ly/2UGT5lH #HarvardHealth
Image from Harvard Health (@HarvardHealth)
17
2
46
A slew of studies has highlighted an amino-acid change present in the Delta variant of SARS-CoV-2 that might contribute to its swift spread. go.nature.com/2WGzrqS
The mutation that helps Delta spread like wildfire

The mutation that helps Delta spread like wildfire

Nature - A key amino-acid change might underlie the coronavirus variant’s ferocious infectivity.

nature.com
4
56
1
119
Inflammatory foods are linked with higher colon cancer risk: bit.ly/2Un9U4Z #HarvardHealth
Image from Harvard Health (@HarvardHealth)
2
62
4
159
Roots Analysis retweeted
UIPSconnect (@UIPSconnect) profile picture
UIPSconnect@UIPSconnect13 Aug 2021
#Uips wishes you Good Luck for the future. #pu #Congratulations
Image from UIPSconnect (@UIPSconnect)
1
4
What happened to string theory, once the hottest thing in physics? pst.cr/RwgK1
4
9
1
17
It's #WorldHepatitisDay Elimination of viral #hepatitis can’t wait: 350 million people have chronic hepatitis B & C around the 🌍 Let's work together to eliminate viral hepatitis as a public health threat by 2030. A hepatitis-free future is possible! 👉bit.ly/3727CuG
40
470
58
821
Should Children Get COVID Vaccines? What the Science Says dlvr.it/S4CD0f
Image from Biotechnology (@Biotechnology)
1
5
Early detection of fibrosis plays a critical role in facilitating successful treatment of the disease. @RootsAnalysis rootsanalysis.com/blog/non-i… #Rootsanalysis #Fibrosis #Diseases #Research #market #Biotech #Pharma
2
2
Oligonucleotide are short single stranded DNA or RNA molecules, typically containing 15-20 nucleotide residues. @RootsAnalysis rootsanalysis.com/blog/antis… #Rootsanalysis #Oligonucleotide #Pharma #Biotech #Research #Market
1
2
Image from lamarkbiotech (@lamarkbiotech)
1
1
3
COVID-19 has nearly doubled the need of #ColdChain #Logistics for #vaccines. @RootsAnalysis suggest a dependence worth USD 5.8 Billion in 2030 for vaccine logistics. Lamark is committed to cut half this burden. @BIRAC_2012 @IKP_SciencePark @venture_center @Genopole
1
7
According to the World Bank, more than 50,000 different types of medical devices are currently being used on a daily basis in healthcare facilities across the globe. Source - rootsanalysis.com/reports/vi… #Medical #Device #CROs #RootsAnalysis #Research #Pharma
Image from Roots Analysis (@RootsAnalysis)
1
3
"This could delay COVAX deliveries and create exactly the scenario COVAX was designed to avoid, with hoarding, a chaotic market, an uncoordinated response, and continued social and economic disruption"-@DrTedros #EB148 #COVID19 #ACTogether teapawt.org/WHO/status/13511079588…
World Health Organization (WHO) (@WHO) profile pictureWorld Health Organization (WHO)
@WHO18 Jan 2021
Replying to @WHO
"44 bilateral deals were signed last year, and at least 12 have already been signed this year"-@DrTedros #EB148 #COVID19 teapawt.org/WHO/status/13511076514…
Image from World Health Organization (WHO) (@WHO)
4
32
3
70
"44 bilateral deals were signed last year, and at least 12 have already been signed this year"-@DrTedros #EB148 #COVID19 teapawt.org/WHO/status/13511076514…
Image from World Health Organization (WHO) (@WHO)
World Health Organization (WHO) (@WHO) profile pictureWorld Health Organization (WHO)
@WHO18 Jan 2021
Replying to @WHO
"Even as they speak the language of equitable access, some countries and companies continue to prioritize bilateral deals, going around COVAX, driving up prices and attempting to jump to the front of the queue"-@DrTedros #EB148 #COVID19 #ACTogether
7
24
1
66
Roots Analysis retweeted
Biocon (@Bioconlimited) profile picture
Biocon
@Bioconlimited29 Dec 2020
"The launch of Tacrolimus capsules in the US is another milestone for #Biocon that reflects our commitment to continually evaluate & expand our portfolio of complex products to serve patients." Siddharth Mittal, CEO & MD. Read more: bit.ly/37Vmson
Image from Biocon (@Bioconlimited)
3
9
The microbial contract biomanufacturing market is projected to be worth USD 9․3 billion by 2030, growing at a CAGR of 8․7%, claims Roots Analysis s.einnews.com/K9xPLlde5J
1
Load more